What is Pluri Operating Cash Flow per Share?
Pluri's operating cash flow per share for the
three
months ended in Mar. 2024 was $-0.81.
Pluri's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.21.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Pluri's Operating Cash Flow per Share or its related term are showing as below:
PLUR'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -165.3 Med: 16.3 Max: 60.3
Current: 24.5
During the past 13 years, Pluri's highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.30% per year. The lowest was -165.30% per year. And the median was 16.30% per year.
Pluri Operating Cash Flow per Share Historical Data
The historical data trend for Pluri's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pluri Operating Cash Flow per Share Chart
|
Pluri Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Operating Cash Flow per Share |
|
Get a 7-Day Free Trial
|
|
|
-19.10 |
-11.59 |
-8.80 |
-9.07 |
-4.99 |
|
Pluri Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Operating Cash Flow per Share |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
-1.22 |
-0.57 |
-1.13 |
-0.70 |
-0.81 |
Competitive Comparison of Pluri's Operating Cash Flow per Share
For the Biotechnology subindustry, Pluri's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pluri's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pluri's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Pluri's Price-to-Operating-Cash-Flow falls into.
Pluri Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Pluri's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as
Pluri's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.21
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pluri (PLUR) Business Description
Traded in Other Exchanges
Address
MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility.
Executives
| Lorne Kenneth Abony |
director |
MATAM PARK, BUILDING #5, HAIFA L3 3508409 |
| Zami Aberman |
officer: Chief Executive Officer |
63 RABUTZKY STREET, RAANANA L3 43220 |
| Varda Shalev |
director |
MATAM PARK, BUILDING #5, HAIFA L3 3508409 |
| Pinhas Doron Birger |
director |
MATAM PARK, BUILDING #5, HAIFA L3 3508409 |
| Clover Wolf Capital - Limited Partnership |
10 percent owner |
BOODENHIMER 24, TEL AVIV L3 6200838 |
| Rami Avraham Levi |
director |
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409 |
| Maital Shemesh-rasmussen |
director |
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409 |
| Doron Shorrer |
director |
33 KOREH PLADORR ST, JERUSALEM L3 93393 |
| Isaac Braun |
director |
9 ZEHARIA STREET, BENE BARAK L3 51540 |
| Yaky Yanay |
officer: Chief Financial Officer |
ARGAMAN 14, SHIMSHIT L3 17906 |
| Moria Kwiat |
director |
HAKFAR 11, KIRYAT ONO L3 55525 |
| Israel Ben-yoram |
director |
24 BARKAN STREET, RISHON LEZION L3 00000 |
| Chen Franco-yehuda |
officer: Chief Financial Officer |
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 31905 |
| Mark Germain |
director |
WELLSFORD REAL PROPERTIES INC, 535 MADISON AVENUE, NEW YORK NY 10022 |
| Erez Egozi |
officer: Chief Financial Officer |
MATAM PARK, BUILDING 05, HAIFA L3 31905 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLUR has been successfully added to your